The introduction of a 750mcg teriparatide injection in Australia has recently changed treatment options for patients with severe bone loss . Currently , this higher dosage product is accessible through limited healthcare providers and medical centers nationwide , depending on strict prescription guidelines. Turnover figures for the 750mcg therapy r